25 XP   0   0   10

MeVis Medical Solutions AG
Buy, Hold or Sell?

Let's analyse Mevis together

PenkeI guess you are interested in MeVis Medical Solutions AG. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of MeVis Medical Solutions AG. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about MeVis Medical Solutions AG

I send you an email if I find something interesting about MeVis Medical Solutions AG.

Quick analysis of Mevis (30 sec.)










What can you expect buying and holding a share of Mevis? (30 sec.)

How much money do you get?

How much money do you get?
€18.52
When do you have the money?
1 year
How often do you get paid?
90.0%

What is your share worth?

Current worth
€9.79
Expected worth in 1 year
€9.79
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
€17.12
Return On Investment
68.5%

For what price can you sell your share?

Current Price per Share
€25.00
Expected price per share
€22.32 - €24.82
How sure are you?
50%

1. Valuation of Mevis (5 min.)




Live pricePrice per Share (EOD)

€25.00

Intrinsic Value Per Share

€24.73 - €55.12

Total Value Per Share

€34.52 - €64.91

2. Growth of Mevis (5 min.)




Is Mevis growing?

Current yearPrevious yearGrowGrow %
How rich?$19.2m$19.2m0.000.0%

How much money is Mevis making?

Current yearPrevious yearGrowGrow %
Making money$5.3m$8.4m-$3.1m-58.3%
Net Profit Margin28.4%41.5%--

How much money comes from the company's main activities?

3. Financial Health of Mevis (5 min.)




4. Comparing to competitors in the Health Information Services industry (5 min.)




  Industry Rankings (Health Information Services)  


Richest
#74 / 122

Most Revenue
#53 / 122

Most Profit
#22 / 122

What can you expect buying and holding a share of Mevis? (5 min.)

Welcome investor! Mevis's management wants to use your money to grow the business. In return you get a share of Mevis.

What can you expect buying and holding a share of Mevis?

First you should know what it really means to hold a share of Mevis. And how you can make/lose money.

Speculation

The Price per Share of Mevis is €25.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Mevis.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Mevis, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €9.79. Based on the TTM, the Book Value Change Per Share is €0.00 per quarter. Based on the YOY, the Book Value Change Per Share is €0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €4.28 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Mevis.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps2.9211.7%2.9211.7%4.6318.5%3.6914.8%3.4613.8%
Usd Book Value Change Per Share0.000.0%0.000.0%0.000.0%-1.69-6.8%-0.51-2.0%
Usd Dividend Per Share4.6318.5%4.6318.5%2.7010.8%2.5210.1%2.118.4%
Usd Total Gains Per Share4.6318.5%4.6318.5%2.7010.8%0.833.3%1.606.4%
Usd Price Per Share30.72-30.72-36.99-33.92-32.91-
Price to Earnings Ratio10.51-10.51-7.99-9.68-10.19-
Price-to-Total Gains Ratio6.64-6.64-13.69-12.65--8.24-
Price to Book Ratio2.90-2.90-3.49-3.20-2.43-
Price-to-Total Gains Ratio6.64-6.64-13.69-12.65--8.24-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share27.0425
Number of shares36
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share4.632.52
Usd Book Value Change Per Share0.00-1.69
Usd Total Gains Per Share4.630.83
Gains per Quarter (36 shares)166.6629.94
Gains per Year (36 shares)666.63119.75
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
16670657363-244110
2133301324727-487230
32000019911090-731350
42667026581453-975470
53333033251817-1218590
64000039922180-1462710
74666046592544-1705830
85333053262907-1949950
96000059933270-21931070
106666066603634-24361190

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%16.02.00.088.9%
Book Value Change Per Share0.00.01.00.0%1.01.01.033.3%2.02.01.040.0%4.05.01.040.0%9.08.01.050.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.01.090.0%9.00.09.050.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%8.02.00.080.0%13.05.00.072.2%

Fundamentals of Mevis

About MeVis Medical Solutions AG

MeVis Medical Solutions AG develops, markets, and sells software for analyzing and evaluating image data to equipment manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company's clinical focuses are image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological disorders. It offers X-ray modalities, including computed tomography, digital mammography, digital tomosynthesis, magnetic resonance imaging, and digital sonography; and provides services in the field of software programming for medical technology companies, which comprise provision of software developers, product and project managers, application specialists, and test engineers. The company also offers three-dimensional technical visualizations; and interactive online training to enhance the diagnostic skills of clinicians, as well as internet-based special applications in teleradiology. In addition, its services are used for technical visualization and online training. The company was founded in 1997 and is based in Bremen, Germany. MeVis Medical Solutions AG operates as a subsidiary of Varex Imaging Deutschland AG.

Fundamental data was last updated by Penke on 2024-03-19 17:28:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is unable to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of MeVis Medical Solutions AG.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Mevis earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Mevis to the Health Information Services industry mean.
  • A Net Profit Margin of 28.4% means that €0.28 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of MeVis Medical Solutions AG:

  • The MRQ is 28.4%. The company is making a huge profit. +2
  • The TTM is 28.4%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ28.4%TTM28.4%0.0%
TTM28.4%YOY41.5%-13.1%
TTM28.4%5Y35.2%-6.8%
5Y35.2%10Y34.8%+0.4%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ28.4%-19.8%+48.2%
TTM28.4%-22.9%+51.3%
YOY41.5%-28.3%+69.8%
5Y35.2%-34.7%+69.9%
10Y34.8%-42.6%+77.4%
1.1.2. Return on Assets

Shows how efficient Mevis is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Mevis to the Health Information Services industry mean.
  • 17.5% Return on Assets means that Mevis generated €0.18 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of MeVis Medical Solutions AG:

  • The MRQ is 17.5%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 17.5%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ17.5%TTM17.5%0.0%
TTM17.5%YOY25.0%-7.4%
TTM17.5%5Y22.7%-5.1%
5Y22.7%10Y17.6%+5.1%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ17.5%-4.7%+22.2%
TTM17.5%-5.8%+23.3%
YOY25.0%-5.3%+30.3%
5Y22.7%-6.1%+28.8%
10Y17.6%-8.2%+25.8%
1.1.3. Return on Equity

Shows how efficient Mevis is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Mevis to the Health Information Services industry mean.
  • 27.6% Return on Equity means Mevis generated €0.28 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of MeVis Medical Solutions AG:

  • The MRQ is 27.6%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 27.6%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ27.6%TTM27.6%0.0%
TTM27.6%YOY43.7%-16.1%
TTM27.6%5Y34.8%-7.2%
5Y34.8%10Y25.6%+9.2%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ27.6%-4.5%+32.1%
TTM27.6%-6.0%+33.6%
YOY43.7%-7.9%+51.6%
5Y34.8%-8.1%+42.9%
10Y25.6%-9.6%+35.2%

1.2. Operating Efficiency of MeVis Medical Solutions AG.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Mevis is operating .

  • Measures how much profit Mevis makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Mevis to the Health Information Services industry mean.
  • An Operating Margin of 29.3% means the company generated €0.29  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of MeVis Medical Solutions AG:

  • The MRQ is 29.3%. The company is operating very efficient. +2
  • The TTM is 29.3%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ29.3%TTM29.3%0.0%
TTM29.3%YOY42.0%-12.7%
TTM29.3%5Y36.5%-7.3%
5Y36.5%10Y38.0%-1.4%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ29.3%-17.8%+47.1%
TTM29.3%-12.5%+41.8%
YOY42.0%-25.0%+67.0%
5Y36.5%-19.8%+56.3%
10Y38.0%-29.4%+67.4%
1.2.2. Operating Ratio

Measures how efficient Mevis is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Health Information Services industry mean).
  • An Operation Ratio of 0.72 means that the operating costs are €0.72 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of MeVis Medical Solutions AG:

  • The MRQ is 0.717. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.717. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.717TTM0.7170.000
TTM0.717YOY0.660+0.057
TTM0.7175Y0.666+0.051
5Y0.66610Y0.681-0.015
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7171.278-0.561
TTM0.7171.380-0.663
YOY0.6601.407-0.747
5Y0.6661.346-0.680
10Y0.6811.331-0.650

1.3. Liquidity of MeVis Medical Solutions AG.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Mevis is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Health Information Services industry mean).
  • A Current Ratio of 1.66 means the company has €1.66 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of MeVis Medical Solutions AG:

  • The MRQ is 1.660. The company is able to pay all its short-term debts. +1
  • The TTM is 1.660. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.660TTM1.6600.000
TTM1.660YOY1.499+0.161
TTM1.6605Y1.655+0.005
5Y1.65510Y2.055-0.400
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6601.660+0.000
TTM1.6601.750-0.090
YOY1.4992.048-0.549
5Y1.6552.606-0.951
10Y2.0552.588-0.533
1.3.2. Quick Ratio

Measures if Mevis is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Mevis to the Health Information Services industry mean.
  • A Quick Ratio of -0.75 means the company can pay off €-0.75 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of MeVis Medical Solutions AG:

  • The MRQ is -0.752. The company is unable to pay all its short-term debts with the most liquid assets. -2
  • The TTM is -0.752. The company is unable to pay all its short-term debts with the most liquid assets. -2
Trends
Current periodCompared to+/- 
MRQ-0.752TTM-0.7520.000
TTM-0.752YOY-0.224-0.528
TTM-0.7525Y-0.126-0.626
5Y-0.12610Y1.307-1.433
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.7521.103-1.855
TTM-0.7521.205-1.957
YOY-0.2241.696-1.920
5Y-0.1261.956-2.082
10Y1.3071.869-0.562

1.4. Solvency of MeVis Medical Solutions AG.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Mevis assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Mevis to Health Information Services industry mean.
  • A Debt to Asset Ratio of 0.36 means that Mevis assets are financed with 36.5% credit (debt) and the remaining percentage (100% - 36.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of MeVis Medical Solutions AG:

  • The MRQ is 0.365. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.365. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.365TTM0.3650.000
TTM0.365YOY0.429-0.064
TTM0.3655Y0.352+0.013
5Y0.35210Y0.297+0.055
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3650.424-0.059
TTM0.3650.428-0.063
YOY0.4290.394+0.035
5Y0.3520.411-0.059
10Y0.2970.446-0.149
1.4.2. Debt to Equity Ratio

Measures if Mevis is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Mevis to the Health Information Services industry mean.
  • A Debt to Equity ratio of 57.4% means that company has €0.57 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of MeVis Medical Solutions AG:

  • The MRQ is 0.574. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.574. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.574TTM0.5740.000
TTM0.574YOY0.750-0.177
TTM0.5745Y0.554+0.020
5Y0.55410Y0.440+0.114
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5740.608-0.034
TTM0.5740.612-0.038
YOY0.7500.648+0.102
5Y0.5540.713-0.159
10Y0.4400.655-0.215

2. Market Valuation of MeVis Medical Solutions AG

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Mevis generates.

  • Above 15 is considered overpriced but always compare Mevis to the Health Information Services industry mean.
  • A PE ratio of 10.51 means the investor is paying €10.51 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of MeVis Medical Solutions AG:

  • The EOD is 9.249. Based on the earnings, the company is underpriced. +1
  • The MRQ is 10.507. Based on the earnings, the company is underpriced. +1
  • The TTM is 10.507. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD9.249MRQ10.507-1.258
MRQ10.507TTM10.5070.000
TTM10.507YOY7.991+2.515
TTM10.5075Y9.683+0.823
5Y9.68310Y10.194-0.511
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD9.249-1.283+10.532
MRQ10.507-1.334+11.841
TTM10.507-1.554+12.061
YOY7.991-3.218+11.209
5Y9.683-6.379+16.062
10Y10.194-6.194+16.388
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of MeVis Medical Solutions AG:

  • The EOD is 7.880. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 8.951. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 8.951. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD7.880MRQ8.951-1.072
MRQ8.951TTM8.9510.000
TTM8.951YOY13.175-4.224
TTM8.9515Y11.595-2.644
5Y11.59510Y9.461+2.135
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD7.880-2.127+10.007
MRQ8.951-2.380+11.331
TTM8.951-3.119+12.070
YOY13.175-5.407+18.582
5Y11.595-6.386+17.981
10Y9.461-7.012+16.473
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Mevis is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Health Information Services industry mean).
  • A PB ratio of 2.90 means the investor is paying €2.90 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of MeVis Medical Solutions AG:

  • The EOD is 2.552. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.900. Based on the equity, the company is underpriced. +1
  • The TTM is 2.900. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.552MRQ2.900-0.347
MRQ2.900TTM2.9000.000
TTM2.900YOY3.492-0.592
TTM2.9005Y3.202-0.302
5Y3.20210Y2.428+0.774
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD2.5521.550+1.002
MRQ2.9001.714+1.186
TTM2.9001.863+1.037
YOY3.4922.896+0.596
5Y3.2024.345-1.143
10Y2.4284.157-1.729
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of MeVis Medical Solutions AG compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share----0%0.000-100%-1.5640%-0.4740%
Book Value Per Share--9.7959.7950%9.7950%9.795+0%13.769-29%
Current Ratio--1.6601.6600%1.499+11%1.655+0%2.055-19%
Debt To Asset Ratio--0.3650.3650%0.429-15%0.352+4%0.297+23%
Debt To Equity Ratio--0.5740.5740%0.750-24%0.554+4%0.440+30%
Dividend Per Share--4.2804.2800%2.498+71%2.333+83%1.950+120%
Eps--2.7032.7030%4.280-37%3.410-21%3.195-15%
Free Cash Flow Per Share--3.1733.1730%2.596+22%3.155+1%3.105+2%
Free Cash Flow To Equity Per Share---1.107-1.1070%0.098-1227%0.822-235%0.764-245%
Gross Profit Margin--1.0001.0000%1.0000%0.994+1%0.996+0%
Intrinsic Value_10Y_max--55.120--------
Intrinsic Value_10Y_min--24.727--------
Intrinsic Value_1Y_max--4.013--------
Intrinsic Value_1Y_min--2.977--------
Intrinsic Value_3Y_max--13.208--------
Intrinsic Value_3Y_min--8.566--------
Intrinsic Value_5Y_max--23.791--------
Intrinsic Value_5Y_min--13.695--------
Market Cap45500000.000-14%51688000.00051688000.0000%62244000.000-17%57075200.000-9%55368040.000-7%
Net Profit Margin--0.2840.2840%0.415-32%0.352-19%0.348-18%
Operating Margin--0.2930.2930%0.420-30%0.365-20%0.380-23%
Operating Ratio--0.7170.7170%0.660+9%0.666+8%0.681+5%
Pb Ratio2.552-14%2.9002.9000%3.492-17%3.202-9%2.428+19%
Pe Ratio9.249-14%10.50710.5070%7.991+31%9.683+9%10.194+3%
Price Per Share25.000-14%28.40028.4000%34.200-17%31.360-9%30.422-7%
Price To Free Cash Flow Ratio7.880-14%8.9518.9510%13.175-32%11.595-23%9.461-5%
Price To Total Gains Ratio5.842-14%6.6366.6360%13.693-52%12.655-48%-8.241+224%
Quick Ratio---0.752-0.7520%-0.224-70%-0.126-83%1.307-158%
Return On Assets--0.1750.1750%0.250-30%0.227-23%0.1760%
Return On Equity--0.2760.2760%0.437-37%0.348-21%0.256+8%
Total Gains Per Share--4.2804.2800%2.498+71%0.769+457%1.476+190%
Usd Book Value--19282406.91619282406.9160%19282406.9160%19282406.652+0%27106115.186-29%
Usd Book Value Change Per Share----0%0.000-100%-1.6920%-0.5120%
Usd Book Value Per Share--10.59510.5950%10.5950%10.595+0%14.893-29%
Usd Dividend Per Share--4.6294.6290%2.702+71%2.523+83%2.109+120%
Usd Eps--2.9242.9240%4.629-37%3.688-21%3.456-15%
Usd Free Cash Flow--6246183.6246246183.6240%5110358.439+22%6210742.625+1%5501553.153+14%
Usd Free Cash Flow Per Share--3.4323.4320%2.808+22%3.412+1%3.359+2%
Usd Free Cash Flow To Equity Per Share---1.197-1.1970%0.106-1227%0.889-235%0.827-245%
Usd Market Cap49217350.000-14%55910909.60055910909.6000%67329334.800-17%61738243.840-9%59891608.868-7%
Usd Price Per Share27.043-14%30.72030.7200%36.994-17%33.922-9%32.907-7%
Usd Profit--5321472.9085321472.9080%8425412.140-37%6712839.925-21%6240881.182-15%
Usd Revenue--18758841.40018758841.4000%20294855.400-8%18934509.480-1%17741610.720+6%
Usd Total Gains Per Share--4.6294.6290%2.702+71%0.832+457%1.597+190%
 EOD+4 -4MRQTTM+0 -0YOY+13 -195Y+15 -1910Y+13 -21

3.2. Fundamental Score

Let's check the fundamental score of MeVis Medical Solutions AG based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-159.249
Price to Book Ratio (EOD)Between0-12.552
Net Profit Margin (MRQ)Greater than00.284
Operating Margin (MRQ)Greater than00.293
Quick Ratio (MRQ)Greater than1-0.752
Current Ratio (MRQ)Greater than11.660
Debt to Asset Ratio (MRQ)Less than10.365
Debt to Equity Ratio (MRQ)Less than10.574
Return on Equity (MRQ)Greater than0.150.276
Return on Assets (MRQ)Greater than0.050.175
Total8/10 (80.0%)

3.3. Technical Score

Let's check the technical score of MeVis Medical Solutions AG based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.519
Ma 20Greater thanMa 5024.820
Ma 50Greater thanMa 10024.852
Ma 100Greater thanMa 20024.984
OpenGreater thanClose25.000
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets28,054
Total Liabilities10,228
Total Stockholder Equity17,826
 As reported
Total Liabilities 10,228
Total Stockholder Equity+ 17,826
Total Assets = 28,054

Assets

Total Assets28,054
Total Current Assets11,371
Long-term Assets16,683
Total Current Assets
Cash And Cash Equivalents 7,744
Short-term Investments -16,225
Net Receivables 3,332
Other Current Assets 314
Total Current Assets  (as reported)11,371
Total Current Assets  (calculated)-4,836
+/- 16,206
Long-term Assets
Property Plant Equipment 146
Long-term Assets Other 0
Long-term Assets  (as reported)16,683
Long-term Assets  (calculated)146
+/- 16,537

Liabilities & Shareholders' Equity

Total Current Liabilities6,849
Long-term Liabilities3,379
Total Stockholder Equity17,826
Total Current Liabilities
Short-term Debt -1,660
Accounts payable 77
Other Current Liabilities 6,772
Total Current Liabilities  (as reported)6,849
Total Current Liabilities  (calculated)5,189
+/- 1,660
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,660
Long-term Liabilities  (as reported)3,379
Long-term Liabilities  (calculated)1,660
+/- 1,720
Total Stockholder Equity
Common Stock1,820
Retained Earnings 4,540
Accumulated Other Comprehensive Income 5
Other Stockholders Equity 11,461
Total Stockholder Equity (as reported)17,826
Total Stockholder Equity (calculated)17,826
+/-0
Other
Capital Stock1,820
Cash and Short Term Investments 7,744
Common Stock Shares Outstanding 1,820
Current Deferred Revenue1,660
Liabilities and Stockholders Equity 28,054
Net Debt -7,744
Net Invested Capital 17,826
Net Working Capital 4,522
Property Plant and Equipment Gross 1,991



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2023-09-302022-09-302021-09-302020-09-302019-09-302018-09-302017-09-302016-09-302015-09-302014-09-302013-09-302012-09-302011-09-302010-09-302009-09-302008-09-302007-09-302006-09-30
> Total Assets 
9,103
35,575
59,584
50,955
38,785
32,549
30,915
34,373
38,254
45,549
43,003
49,079
38,419
23,920
27,791
27,534
31,201
28,054
28,05431,20127,53427,79123,92038,41949,07943,00345,54938,25434,37330,91532,54938,78550,95559,58435,5759,103
   > Total Current Assets 
7,853
32,676
28,883
21,082
14,578
12,665
13,419
17,505
20,688
28,720
26,904
33,414
7,155
7,121
11,057
10,874
14,502
11,371
11,37114,50210,87411,0577,1217,15533,41426,90428,72020,68817,50513,41912,66514,57821,08228,88332,6767,853
       Cash And Cash Equivalents 
5,428
28,471
15,257
7,718
5,621
6,076
8,149
9,893
9,267
25,621
24,356
29,735
3,477
2,600
3,954
7,621
9,320
7,744
7,7449,3207,6213,9542,6003,47729,73524,35625,6219,2679,8938,1496,0765,6217,71815,25728,4715,428
       Short-term Investments 
365
559
9,159
0
2,882
1,740
582
4,233
8,285
50
20
2
1
1
-16,225
-16,225
-16,225
-16,225
-16,225-16,225-16,225-16,22511220508,2854,2335821,7402,88209,159559365
       Net Receivables 
0
0
0
0
0
0
0
0
2,820
2,836
2,203
3,677
3,573
4,412
6,646
2,799
4,738
3,332
3,3324,7382,7996,6464,4123,5733,6772,2032,8362,82000000000
       Inventory 
30
8
154
130
86
257
181
0
0
0
0
0
0
0
48
100
133
-19
-1913310048000000018125786130154830
       Other Current Assets 
2,030
3,638
4,313
13,234
5,989
4,592
4,507
3,379
3,136
3,049
30
3,677
3,678
14
409
354
310
314
314310354409143,6783,677303,0493,1363,3794,5074,5925,98913,2344,3133,6382,030
   > Long-term Assets 
1,250
2,899
30,701
29,873
24,207
19,884
17,496
16,868
17,566
16,829
0
15,665
31,264
16,799
16,734
16,659
16,699
16,683
16,68316,69916,65916,73416,79931,26415,665016,82917,56616,86817,49619,88424,20729,87330,7012,8991,250
       Property Plant Equipment 
287
398
1,414
1,191
926
685
316
505
374
319
316
316
215
243
194
122
162
146
1461621221942432153163163193745053166859261,1911,414398287
       Goodwill 
0
0
0
0
0
0
10,625
10,625
10,625
10,625
10,625
10,625
10,625
0
0
0
0
0
0000010,62510,62510,62510,62510,62510,62510,625000000
       Long Term Investments 
0
0
0
0
0
0
0
0
1,571
1,718
1,611
1,991
312
312
0
0
0
0
00003123121,9911,6111,7181,57100000000
       Intangible Assets 
389
1,388
26,876
27,095
22,001
18,921
6,220
5,738
4,996
3,229
2,093
1,097
492
18
2
0
0
0
0002184921,0972,0933,2294,9965,7386,22018,92122,00127,09526,8761,388389
       Other Assets 
0
0
0
0
0
0
0
0
0
938
1,454
1,636
16,329
0
16,274
0
16,359
0
016,359016,274016,3291,6361,454938000000000
> Total Liabilities 
6,450
4,806
26,973
18,348
13,996
11,820
8,146
7,928
7,984
11,820
10,114
16,568
6,360
6,094
9,965
9,708
13,375
10,228
10,22813,3759,7089,9656,0946,36016,56810,11411,8207,9847,9288,14611,82013,99618,34826,9734,8066,450
   > Total Current Liabilities 
5,884
4,117
13,029
11,323
8,143
7,582
5,637
5,921
5,382
11,671
9,845
16,267
6,033
3,558
7,476
6,655
9,672
6,849
6,8499,6726,6557,4763,5586,03316,2679,84511,6715,3825,9215,6377,5828,14311,32313,0294,1175,884
       Short-term Debt 
1
154
465
401
2,882
1,740
179
159
283
4,742
0
9,368
1,619
0
-1,566
-1,759
-1,517
-1,660
-1,660-1,517-1,759-1,56601,6199,36804,7422831591791,7402,8824014651541
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
9,368
1,619
0
0
0
0
0
000001,6199,36800000000000
       Accounts payable 
438
652
1,038
1,121
1,317
1,168
1,144
836
579
553
327
279
336
11
93
240
193
77
7719324093113362793275535798361,1441,1681,3171,1211,038652438
       Other Current Liabilities 
5,445
3,311
11,526
9,801
6,826
6,414
4,314
4,926
4,520
6,376
7,908
6,620
2,769
3,547
7,383
6,415
9,479
6,772
6,7729,4796,4157,3833,5472,7696,6207,9086,3764,5204,9264,3146,4146,8269,80111,5263,3115,445
   > Long-term Liabilities 
566
689
13,944
7,025
5,853
4,238
2,509
2,007
2,602
149
0
301
327
2,536
2,489
3,053
3,704
3,379
3,3793,7043,0532,4892,53632730101492,6022,0072,5094,2385,8537,02513,944689566
       Other Liabilities 
0
0
0
0
0
0
0
0
2,602
149
269
301
1,971
2,119
6,176
5,610
10,369
0
010,3695,6106,1762,1191,9713012691492,60200000000
> Total Stockholder Equity
2,653
30,769
32,611
32,607
24,789
20,729
22,769
26,445
30,270
33,729
32,889
32,511
32,059
17,826
17,826
17,826
17,826
17,826
17,82617,82617,82617,82617,82632,05932,51132,88933,72930,27026,44522,76920,72924,78932,60732,61130,7692,653
   Common Stock
50
1,820
1,820
1,820
1,820
1,820
1,820
1,820
1,820
1,820
1,820
1,820
1,820
1,820
1,820
1,820
1,820
1,820
1,8201,8201,8201,8201,8201,8201,8201,8201,8201,8201,8201,8201,8201,8201,8201,8201,82050
   Retained Earnings 
2,603
2,245
4,368
4,939
-3,180
-7,020
-4,585
17,561
21,305
23,298
22,524
22,990
22,625
4,540
4,540
4,540
4,540
4,540
4,5404,5404,5404,5404,54022,62522,99022,52423,29821,30517,561-4,585-7,020-3,1804,9394,3682,2452,603
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
8,219
7,475
11,461
11,461
11,461
11,461
11,461
0
011,46111,46111,46111,46111,4617,4758,2190000000000
   Treasury Stock000000000000000000
   Other Stockholders Equity 
0
26,704
26,423
25,848
28,167
25,929
27,369
9,081
8,263
9,938
326
226
8,825
11,466
11,461
11,461
11,461
11,461
11,46111,46111,46111,46111,4668,8252263269,9388,2639,08127,36925,92928,16725,84826,42326,7040



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2023-09-30)

Gross Profit (+$)
totalRevenue17,342
Cost of Revenue-445
Gross Profit16,89716,897
 
Operating Income (+$)
Gross Profit16,897
Operating Expense-11,992
Operating Income5,0774,905
 
Operating Expense (+$)
Research Development-
Selling General Administrative442
Selling And Marketing Expenses-
Operating Expense11,992442
 
Net Interest Income (+$)
Interest Income111
Interest Expense-43
Other Finance Cost-0
Net Interest Income68
 
Pretax Income (+$)
Operating Income5,077
Net Interest Income68
Other Non-Operating Income Expenses-
Income Before Tax (EBT)5,0345,119
EBIT - interestExpense = 5,034
5,034
4,962
Interest Expense43
Earnings Before Interest and Taxes (EBIT)5,0775,077
Earnings Before Interest and Taxes (EBITDA)5,172
 
After tax Income (+$)
Income Before Tax5,034
Tax Provision-114
Net Income From Continuing Ops4,9204,920
Net Income4,920
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses12,437
Total Other Income/Expenses Net-43-68
 

Technical Analysis of Mevis
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Mevis. The general trend of Mevis is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Mevis's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of MeVis Medical Solutions AG.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 24.05 < 24.63 < 24.82.

The bearish price targets are: 23.00 > 22.32.

Tweet this
MeVis Medical Solutions AG Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of MeVis Medical Solutions AG. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

MeVis Medical Solutions AG Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of MeVis Medical Solutions AG. The current macd is -0.013275.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Mevis price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Mevis. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Mevis price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
MeVis Medical Solutions AG Daily Moving Average Convergence/Divergence (MACD) ChartMeVis Medical Solutions AG Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of MeVis Medical Solutions AG. The current adx is 20.76.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Mevis shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
MeVis Medical Solutions AG Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of MeVis Medical Solutions AG. The current sar is 23.19.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
MeVis Medical Solutions AG Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of MeVis Medical Solutions AG. The current rsi is 51.52. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
MeVis Medical Solutions AG Daily Relative Strength Index (RSI) ChartMeVis Medical Solutions AG Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of MeVis Medical Solutions AG. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Mevis price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
MeVis Medical Solutions AG Daily Stochastic Oscillator ChartMeVis Medical Solutions AG Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of MeVis Medical Solutions AG. The current cci is 57.09.

MeVis Medical Solutions AG Daily Commodity Channel Index (CCI) ChartMeVis Medical Solutions AG Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of MeVis Medical Solutions AG. The current cmo is 5.48599312.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
MeVis Medical Solutions AG Daily Chande Momentum Oscillator (CMO) ChartMeVis Medical Solutions AG Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of MeVis Medical Solutions AG. The current willr is -16.66666667.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
MeVis Medical Solutions AG Daily Williams %R ChartMeVis Medical Solutions AG Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of MeVis Medical Solutions AG.

MeVis Medical Solutions AG Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of MeVis Medical Solutions AG. The current atr is 0.38053377.

MeVis Medical Solutions AG Daily Average True Range (ATR) ChartMeVis Medical Solutions AG Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of MeVis Medical Solutions AG. The current obv is -7,159.

MeVis Medical Solutions AG Daily On-Balance Volume (OBV) ChartMeVis Medical Solutions AG Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of MeVis Medical Solutions AG. The current mfi is 59.08.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
MeVis Medical Solutions AG Daily Money Flow Index (MFI) ChartMeVis Medical Solutions AG Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for MeVis Medical Solutions AG.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-11-13BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-14ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-08MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-11MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-30RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-13BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

MeVis Medical Solutions AG Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of MeVis Medical Solutions AG based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.519
Ma 20Greater thanMa 5024.820
Ma 50Greater thanMa 10024.852
Ma 100Greater thanMa 20024.984
OpenGreater thanClose25.000
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Mevis with someone you think should read this too:
  • Are you bullish or bearish on Mevis? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Mevis? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about MeVis Medical Solutions AG

I send you an email if I find something interesting about MeVis Medical Solutions AG.


Comments

How you think about this?

Leave a comment

Stay informed about MeVis Medical Solutions AG.

Receive notifications about MeVis Medical Solutions AG in your mailbox!